
|Podcasts|April 21, 2021
Dr. Robert J. Hamilton on statin use in men starting ADT for prostate cancer
Author(s)Urology Times staff
Hamilton discusses findings from a recent study published in European Urology.
Advertisement
“The patients who use statins had longer overall survival, longer prostate cancer-specific survival, and a trend towards longer time before they became castration resistant,” Robert J. Hamilton, MD, MPH, says in this podcast. Hamilton is an associate professor of urology at the University of Toronto.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
2
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
3
The Expert APProach: Advancing APP Leadership and Expertise in Urology, With Susanne Quallich, PhD, ANP-BC, NP-C
4
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBC
5










